SB
Publications
22
Views
12,372
Downloads
3,244
Supervised works
0
Items per page
1 - 22 of 22
Title Published in Access level OA Policy Year Views Downloads
A Systematic Review and Meta-Analysis of HCV ClearanceLiver international
accessLevelRestricted
2017 517 1
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant PopulationsPloS one
accessLevelPublic
2016 482 213
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantationKidney international
accessLevelPublic
2016 455 479
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ TransplantClinical infectious diseases
accessLevelRestricted
2015 502 1
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesNature communications
accessLevelPublic
2015 534 144
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ TransplantationThe Journal of infectious diseases
accessLevelRestricted
2015 635 0
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ TransplantationThe Journal of infectious diseases
accessLevelRestricted
2015 582 2
The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infectionAlimentary pharmacology & therapeutics
accessLevelRestricted
2014 574 0
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patientsAIDS
accessLevelRestricted
2014 479 0
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesNature communications
accessLevelPublic
2014 580 1,183
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentPloS one
accessLevelPublic
2013 639 596
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaJournal of hepatology
accessLevelRestricted
2013 605 0
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionThe Journal of experimental medicine
accessLevelRestricted
2013 534 0
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4Journal of viral hepatitis
accessLevelRestricted
2013 587 0
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5Gut
accessLevelRestricted
2012 551 0
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapyHepatology
accessLevelRestricted
2012 547 0
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CPloS one
accessLevelPublic
2012 679 349
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesHepatology
accessLevelRestricted
2012 615 0
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionGastroenterology
accessLevelRestricted
2012 579 0
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinJournal of viral hepatitis
accessLevelRestricted
2012 564 0
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CJournal of hepatology
accessLevelRestricted
2011 557 0
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphismsPloS one
accessLevelPublic
2011 575 276
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack